BIOL 422 is UMGC's three-credit course on the factors behind the emergence of new infectious diseases and the resurgence of diseases once thought to be under control.
The University of Maryland Global Campus says students learn to synthesize research methods and communicate epidemiological knowledge to varied audiences.
The course covers socioeconomic and environmental influences on diseases such as malaria, tuberculosis and AIDS; emerging pathogens such as Lyme disease, E. coli O157, Ebola, hantaviruses and cryptosporidia; and resurgent threats such as anthrax, bubonic plague, dengue, influenza and cholera, including symptoms, transmission and management.
The course asks you to think at population level. The question shifts from "how does this microbe cause disease?" to "why is this disease spreading here, now, and what would stop it?"
Course at a Glance
| Item | Details |
|---|---|
| University | University of Maryland Global Campus (UMGC) |
| Course code | BIOL 422 |
| Credits | 3 |
| Prerequisite | BIOL 230, BIOL 301, BIOL 302 or BIOL 398G |
| Credit note | Credit for only one of BIOL 422 or MICB 388E |
| Typical work | Disease analyses, research syntheses, communication pieces for different audiences |
What BIOL 422 Covers
| Group | Diseases named by UMGC |
|---|---|
| Socioeconomic and environmental focus | Malaria, tuberculosis, AIDS |
| Emerging pathogens | Lyme disease, E. coli O157, Ebola, hantaviruses, cryptosporidia |
| Resurgent threats | Anthrax, bubonic plague, dengue, influenza, cholera |
| For each disease | Symptoms, transmission patterns and management strategies |
Key Concepts Explained
The Epidemiological Triad
Disease results from the interaction of agent (the pathogen), host (the person) and environment (conditions that bring them together). Emergence usually involves a change in one or more of the three.
Example: Lyme disease rose in parts of the north-eastern United States as reforestation and suburban growth brought people, deer and ticks closer together. The bacterium did not change much; the environment and human behavior did.
Measuring Disease
Incidence is the number of new cases in a population over a period; prevalence is the proportion with the disease at a point in time. Case fatality rate is the share of cases who die from the disease.
Example: In a town of 20,000, 50 new cases occur in a year: incidence is 50 / 20,000 = 2.5 per 1,000 per year. If 2 of those 50 die, the case fatality rate is 4 percent.
The Basic Reproduction Number
R0 is the average number of people one case infects in a fully susceptible population. If R0 is above 1, an outbreak can grow; control measures aim to push the effective reproduction number below 1.
Communicating to Different Audiences
UMGC highlights communicating epidemiological knowledge to varied audiences, so expect tasks that change the reader.
| Audience | What they need |
|---|---|
| Public health professionals | Data, methods, rates and evidence for interventions |
| Policymakers | Risk, cost, options and a clear recommendation |
| The public | Plain language, what to do, and why it helps |
The same facts should appear in each version; only the depth, vocabulary and structure change.
Typical Assignments and How to Approach Them
| Assignment type | What it tests | How to approach it |
|---|---|---|
| Disease profile or case study | Emergence, transmission and control | Agent, host, environment, spread, control measures |
| Research synthesis | Combining studies and methods | Compare study designs and what each shows |
| Public communication piece | Tailoring evidence to an audience | Accurate, plain and action-focused |
Epidemiological Study Designs
Synthesizing research methods is one of UMGC's stated outcomes, so you need to recognize the main designs and what each can show.
| Design | What it can show |
|---|---|
| Cross-sectional survey | Prevalence at one point in time |
| Case-control study | Exposures linked to a disease, efficient for rare outcomes |
| Cohort study | Incidence and risk over time in exposed and unexposed groups |
| Randomized trial | Whether an intervention, such as a vaccine, causes a reduction in disease |
When synthesizing studies, compare their designs before their results; a trial and a case-control study answer different questions.
Where Students Get Stuck
- Staying at the microbe level. Bring in social, economic and environmental drivers.
- Confusing incidence and prevalence. Write the definition next to every figure you use.
- Outdated statistics. Use current data from public health agencies and state the year.
- One message for all audiences. Adjust depth and language to the reader.
Study Tips for BIOL 422
- Use the agent-host-environment triad as the outline for every disease you study.
- Practice incidence, prevalence and fatality calculations with simple numbers.
- Follow current outbreak reports and identify what drove each one.
- Revise your microbiology notes from BIOL 230 or BIOL 302.
How We Help with BIOL 422
Send the prompt, rubric, readings and any feedback. A writer with an epidemiology or public health background can explain concepts and measures, prepare a referenced custom paper, or review your draft for accuracy and audience fit.
GradeEssays is independent of the University of Maryland Global Campus. Our work is a study aid: use it to learn, then write and submit your own under UMGC's academic integrity policy. Free revisions within the scope of your original request are included.
Make Epidemiology Make Sense
Share your BIOL 422 assignment and sources. An epidemiology writer prepares a custom paper or reviews your draft.
Start My BIOL 422 HelpFree revisions · Full refund if late · Written from scratch for your order
Frequently Asked Questions
UMGC lists BIOL 230, BIOL 301, BIOL 302 or BIOL 398G.
UMGC names malaria, tuberculosis, AIDS, Lyme disease, E. coli O157, Ebola, hantaviruses, cryptosporidia, anthrax, bubonic plague, dengue, influenza and cholera.
No. UMGC allows credit for only one of the two.
Incidence counts new cases over a period; prevalence is the proportion of people with the disease at a given time.
Common drivers include drug resistance, gaps in vaccination, conflict, poverty, climate and changes in land use.
Yes. We can show how to turn technical findings into clear, accurate public messages.